» Articles » PMID: 8418845

L-29, an Endogenous Lectin, Binds to Glycoconjugate Ligands with Positive Cooperativity

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1993 Jan 12
PMID 8418845
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

The soluble mammalian lactose-binding lectins L-14-I and L-29 are both secreted and bind to oligosaccharides on laminin, a large extracellular matrix glycoprotein containing polylactosamine chains. Because of the potential functional significance of these lectin-laminin interactions, we compared quantitative aspects of L-14-I and L-29 binding to immobilized laminin using recombinant lectins labeled with 125I. We report that the concentration-dependent binding of L-29 exhibits positive cooperativity whereas binding of L-14-I does not. Cooperative binding of L-29 can also occur on glycoconjugate substrates other than laminin and is not dependent on cystine bond formation or aggregation in solution. L-29 contains repetitive sequences within the N-terminal domain not present in L-14-I. This domain is not required for binding activity, but is required for positive cooperativity. Though the precise mechanism of interaction of L-29 with laminin remains to be determined, it apparently results in assembly of a lectin aggregate on the substrate surface, which could have important functional consequences.

Citing Articles

Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer - implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils.

Karlsson V, Stal E, Stoopendahl E, Ivarsson A, Leffler H, Lycke M Front Immunol. 2025; 15:1506236.

PMID: 39759523 PMC: 11695286. DOI: 10.3389/fimmu.2024.1506236.


Exploration into Galectin-3 Driven Endocytosis and Lattices.

Shafaq-Zadah M, Dransart E, Mani S, Sampaio J, Bouidghaghen L, Nilsson U Biomolecules. 2024; 14(9).

PMID: 39334935 PMC: 11430376. DOI: 10.3390/biom14091169.


Heterologous Interactions with Galectins and Chemokines and Their Functional Consequences.

Mayo K Int J Mol Sci. 2023; 24(18).

PMID: 37762385 PMC: 10531749. DOI: 10.3390/ijms241814083.


Short report galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling.

Gedaj A, Zukowska D, Porebska N, Pozniak M, Krzyscik M, Czyrek A Cell Commun Signal. 2023; 21(1):122.

PMID: 37231412 PMC: 10214663. DOI: 10.1186/s12964-023-01144-x.


Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases.

Ahmed R, Anam K, Ahmed H Int J Mol Sci. 2023; 24(9).

PMID: 37175823 PMC: 10179732. DOI: 10.3390/ijms24098116.